Macclesfield, United Kingdom

Richard Albert Norman

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Richard Albert Norman: Innovator in Chemical Compounds

Introduction

Richard Albert Norman is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of chemical compounds, holding a total of 3 patents. His work focuses on the development of innovative solutions for treating cell proliferative disorders.

Latest Patents

Richard's latest patents involve chemical compounds that concern compounds of Formula (I) or pharmaceutically-acceptable salts thereof. These inventions detail processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of cell proliferative disorders. His research aims to provide effective therapeutic options for various medical conditions.

Career Highlights

Richard Albert Norman is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in chemical compounds has positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Richard has collaborated with esteemed colleagues, including Robert Hugh Bradbury and David Buttar. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in their shared field of research.

Conclusion

Richard Albert Norman's contributions to the field of chemical compounds exemplify his dedication to innovation and improving healthcare solutions. His work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…